ESPE2023 Poster Category 1 Fat, Metabolism and Obesity (97 abstracts)
1Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece. 2Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Background: The prevalence of childhood obesity has recently increased, particularly during the COVID-19 pandemic, which has led to lifestyle changes as a result of public health regulations and guidelines introduced by governments worldwide.
Objective: To investigate the effectiveness of novel e-Health applications in addressing childhood obesity prior to and during the Covid-19 outbreak.
Patients and Methods: The study was carried out as part of the four-year European project BigO (http://bigoprogram.eu, Horizon2020, No.727688). Eighty-six (n=86) overweight and obese children and adolescents (mean age±SEM: 11.82±0.25 years; 49 males, 37 females) were studied prospectively for 1 year prior to the pandemic (non-Covid-19 group, n=50) and during the pandemic (Covid-19 group, n=36). The data collection system included the BigO technology platform, which interfaces with a Smartphone and Smartwatch, and records data on diet, sleep and exercise objectively for each patient. Participants used the BigO system for 4 weeks and wore the watch for specific periods during the week. Subsequently, they entered a personalized life-style intervention program for 4 months and used the system again for 4 weeks.
Results: When determining improvement as reduction in BMI category, the program was successful in 36% in the non-Covid-19 subjects versus 58.3% in the Covid-19 group. Body Mass Index (BMI), BMI z-score, insulin resistance indices (HOMA and QUICKI), blood pressure, γ-GT and insulin concentrations decreased, and HDL concentrations increased at 12 months follow-up in both groups (P<0.01). The BMI z-score at 12 months was significantly lower in the Covid-19 compared with the non-Covid-19 group (P<0.05).
Conclusion: Our results indicate better compliance with life-style interventions and improved cardiometabolic risk factors in the Covid-19 group. These novel e-Health applications were effective at managing childhood obesity despite the implications and lifestyle changes owing to the Covid-19 pandemic.